$OLMA ($OLMA) posted quarterly earnings results for Q4 2025 on Monday, March 16th. The company reported earnings of -$0.50 per share, beating estimates of -$0.54 by $0.04. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $OLMA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$OLMA Insider Trading Activity
$OLMA insiders have traded $OLMA stock on the open market 27 times in the past 6 months. Of those trades, 0 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $OLMA stock by insiders over the last 6 months:
- IAN T CLARK has made 0 purchases and 3 sales selling 264,800 shares for an estimated $7,873,109.
- NASEEM ZOJWALLA (Chief Medical Officer) has made 0 purchases and 4 sales selling 269,509 shares for an estimated $7,530,147.
- DAVID C. MYLES (CH. DISCOV. & NON-CLIN DEV OFF) has made 0 purchases and 8 sales selling 161,000 shares for an estimated $4,660,772.
- SHANE WILLIAM CHARLES KOVACS (CH. OPERATING & FINANCIAL OFF.) has made 0 purchases and 2 sales selling 103,822 shares for an estimated $2,980,054.
- SHAWNTE MITCHELL (CHIEF LEGAL OFFICER) has made 0 purchases and 3 sales selling 40,000 shares for an estimated $951,502.
- CYRUS HARMON has made 0 purchases and 7 sales selling 41,370 shares for an estimated $657,435.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OLMA Hedge Fund Activity
We have seen 133 institutional investors add shares of $OLMA stock to their portfolio, and 61 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 4,993,670 shares (+16972.6%) to their portfolio in Q4 2025, for an estimated $124,841,750
- DEEP TRACK CAPITAL, LP removed 3,470,172 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $86,754,300
- SIREN, L.L.C. added 3,300,700 shares (+inf%) to their portfolio in Q4 2025, for an estimated $82,517,500
- JANUS HENDERSON GROUP PLC added 3,124,345 shares (+87.1%) to their portfolio in Q4 2025, for an estimated $78,108,625
- CORMORANT ASSET MANAGEMENT, LP added 2,750,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $68,750,000
- RA CAPITAL MANAGEMENT, L.P. added 2,600,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $65,000,000
- MPM BIOIMPACT LLC removed 2,378,762 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $23,288,079
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OLMA Analyst Ratings
Wall Street analysts have issued reports on $OLMA in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 01/07/2026
- UBS issued a "Buy" rating on 01/07/2026
- Citigroup issued a "Buy" rating on 12/12/2025
- Goldman Sachs issued a "Buy" rating on 11/21/2025
- JP Morgan issued a "Overweight" rating on 11/18/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/18/2025
- Oppenheimer issued a "Outperform" rating on 11/18/2025
To track analyst ratings and price targets for $OLMA, check out Quiver Quantitative's $OLMA forecast page.
$OLMA Price Targets
Multiple analysts have issued price targets for $OLMA recently. We have seen 8 analysts offer price targets for $OLMA in the last 6 months, with a median target of $41.5.
Here are some recent targets:
- Emily Bodnar from HC Wainwright & Co. set a target price of $38.0 on 03/09/2026
- Laura Prendergast from Stifel set a target price of $48.0 on 02/11/2026
- Michael Yee from UBS set a target price of $45.0 on 01/07/2026
- Yigal Nochomovitz from Citigroup set a target price of $60.0 on 12/12/2025
- Matthew Biegler from Oppenheimer set a target price of $48.0 on 12/11/2025
- Richard Law from Goldman Sachs set a target price of $38.0 on 12/11/2025
- Anupam Rama from JP Morgan set a target price of $32.0 on 11/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
